These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37288783)

  • 21. Computational identification of new TKI as potential noncovalent reversible EGFR
    Abdelmalek D; Smaoui F; Frikha F; Ben Marzoug R; Msalbi D; Souissi A; Aifa MS
    J Biomol Struct Dyn; 2024 Jun; 42(9):4870-4887. PubMed ID: 37349947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying novel therapeutic inhibitors to target FMS-like tyrosine kinase-3 (FLT3) against acute myeloid leukemia: a molecular docking, molecular dynamics, and DFT study.
    Islam MR; Osman OI; Hassan WMI
    J Biomol Struct Dyn; 2024; 42(1):82-100. PubMed ID: 36995071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells.
    Tseng WC; Chen CY; Chern CY; Wang CA; Lee WC; Chi YC; Cheng SF; Kuo YT; Chiu YC; Tseng ST; Lin PY; Liou SJ; Li YC; Chen CC
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential edible spices as EGFR and EGFR mutant T790M/L858R inhibitors by structure-based virtual screening and molecular dynamics.
    Ahmad Ansari I; Debnath B; Kar S; Patel HM; Debnath S; Zaki MEA; Pal P
    J Biomol Struct Dyn; 2024 Mar; 42(5):2464-2481. PubMed ID: 37349948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proposing novel MDM2 inhibitors: Combined physics-driven high-throughput virtual screening and in vitro studies.
    Aydin G; Paksoy MN; Orhan MD; Avsar T; Yurtsever M; Durdagi S
    Chem Biol Drug Des; 2020 Jul; 96(1):684-700. PubMed ID: 32691963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of dUTPase of
    Sisodia R; Sarmadhikari D; Mazumdar PA; Asthana S; Madhurantakam C
    J Biomol Struct Dyn; 2024 Oct; 42(16):8598-8623. PubMed ID: 37587906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Synergistic Mechanism of AP2A2 Transcription Factor Inhibition via Molecular Modeling and Simulations as a Novel Computational Approach for Combating Breast Cancer: In Silico Interpretations.
    Niranjan V; Setlur AS; K C; Kumkum S; Dasgupta S; Singh V; Desai V; Kumar J
    Mol Biotechnol; 2024 Sep; 66(9):2497-2521. PubMed ID: 37747672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of potential HER2 inhibitors from
    Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
    J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
    Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
    Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Shunmuga Priya V; Pradiba D; Aarthy M; Singh SK; Achary A; Vasanthi M
    J Biomol Struct Dyn; 2021 Nov; 39(18):7274-7293. PubMed ID: 32873178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach.
    Shanmugam V; Muthukrishnan S
    J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
    Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C
    Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications.
    Binmujlli MA
    Molecules; 2024 Sep; 29(17):. PubMed ID: 39275052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach.
    Islam S; Amin MA; Rengasamy KRR; Mohiuddin AKM; Mahmud S
    Cancer Med; 2024 Aug; 13(15):e70074. PubMed ID: 39101505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD.
    Bouback TA; Pokhrel S; Albeshri A; Aljohani AM; Samad A; Alam R; Hossen MS; Al-Ghamdi K; Talukder MEK; Ahammad F; Qadri I; Simal-Gandara J
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment.
    Zarezade V; Abolghasemi M; Rahim F; Veisi A; Behbahani M
    J Mol Model; 2018 Nov; 24(12):337. PubMed ID: 30415281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploration and evaluation of bioactive phytocompounds against BRCA proteins by
    Prabhavathi H; Dasegowda KR; Renukananda KH; Lingaraju K; Naika HR
    J Biomol Struct Dyn; 2021 Sep; 39(15):5471-5485. PubMed ID: 32643536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational insights into inhibiting EphA2: Integrating structure-based virtual screening, docking, and molecular dynamics simulations for small molecule discovery.
    Mohd Nehal ; Jahanarah Khatoon ; Salman Akhtar ; Ahmad Khan MK
    Cell Mol Biol (Noisy-le-grand); 2024 Sep; 70(8):16-31. PubMed ID: 39262267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential inhibitors against
    Gaur V; Kumar N; Vyas A; Chowdhury D; Singh J; Bera S
    J Biomol Struct Dyn; 2023 Dec; ():1-11. PubMed ID: 38149858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.